These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15272147)

  • 1. APP, NGF & the 'Sunday-driver' in a Trolley on the Road.
    Heese K; Inoue N; Nagai Y; Sawada T
    Restor Neurol Neurosci; 2004; 22(2):131-6. PubMed ID: 15272147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cholinergic system, nerve growth factor and the cytoskeleton.
    Niewiadomska G; Mietelska-Porowska A; Mazurkiewicz M
    Behav Brain Res; 2011 Aug; 221(2):515-26. PubMed ID: 20170684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
    Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
    Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease Neuropathology.
    Canu N; Amadoro G; Triaca V; Latina V; Sposato V; Corsetti V; Severini C; Ciotti MT; Calissano P
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NGF and the Amyloid Precursor Protein in Alzheimer's Disease: From Molecular Players to Neuronal Circuits.
    Triaca V; Ruberti F; Canu N
    Adv Exp Med Biol; 2021; 1331():145-165. PubMed ID: 34453297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease.
    Lad SP; Neet KE; Mufson EJ
    Curr Drug Targets CNS Neurol Disord; 2003 Oct; 2(5):315-34. PubMed ID: 14529363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of nerve growth factor by beta-amyloid-stimulated astrocytes induces p75NTR-dependent tau hyperphosphorylation in cultured hippocampal neurons.
    Sáez ET; Pehar M; Vargas MR; Barbeito L; Maccioni RB
    J Neurosci Res; 2006 Oct; 84(5):1098-106. PubMed ID: 16862561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the term 'trophic' actually mean anti-amyloidogenic? The case of NGF.
    Calissano P; Amadoro G; Matrone C; Ciafrè S; Marolda R; Corsetti V; Ciotti MT; Mercanti D; Di Luzio A; Severini C; Provenzano C; Canu N
    Cell Death Differ; 2010 Jul; 17(7):1126-33. PubMed ID: 20395961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing.
    Marcade M; Bourdin J; Loiseau N; Peillon H; Rayer A; Drouin D; Schweighoffer F; Désiré L
    J Neurochem; 2008 Jul; 106(1):392-404. PubMed ID: 18397369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.
    Bruno MA; Leon WC; Fragoso G; Mushynski WE; Almazan G; Cuello AC
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):857-69. PubMed ID: 19606067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TrkA pathway activation induced by amyloid-beta (Abeta).
    Bulbarelli A; Lonati E; Cazzaniga E; Re F; Sesana S; Barisani D; Sancini G; Mutoh T; Masserini M
    Mol Cell Neurosci; 2009 Mar; 40(3):365-73. PubMed ID: 19162192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
    Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
    Suzuki T; Araki Y; Yamamoto T; Nakaya T
    J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between Alzheimer's disease and cerebral ischemia--focus on inflammation.
    Koistinaho M; Koistinaho J
    Brain Res Brain Res Rev; 2005 Apr; 48(2):240-50. PubMed ID: 15850663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase inhibitors modulate nerve growth factor-mediated regulation of amyloid precursor protein expression in PC12 cells.
    Binnington JC; Kalisch BE
    J Neurochem; 2007 Apr; 101(2):422-33. PubMed ID: 17402971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.
    Fahnestock M; Michalski B; Xu B; Coughlin MD
    Mol Cell Neurosci; 2001 Aug; 18(2):210-20. PubMed ID: 11520181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
    Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
    Pákáski M; Kálmán J
    Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.